Abstract
The fibrinolytic response of 30 diabetic patients and 35 non-diabetics to 0·5 mg. subcutaneous adrenaline was measured, using the dilute clot lysis test. With the exception of two patients out of six who were taking phenformin, who had a depressed response, the diabetics showed a similar increase in fibrinolytic activity to the non-diabetics. The diabetics in this series did not tend to have longer spontaneous lysis times than the non-diabetics, although this type of comparison may not be valid.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- DENBOROUGH M. A., PATERSON B. Clearing factor, fibrinolysis and blood lipids in diabetes mellitus. Clin Sci. 1962 Dec;23:485–488. [PubMed] [Google Scholar]
- FEARNLEY G. R., CHAKRABARTI R. THE PHARMACOLOGICAL ENHANCEMENT OF BLOOD FIBRINOLYTIC ACTIVITY WITH SPECIAL REFERENCE TO PHENFORMIN. Acta Cardiol. 1964;19:1–13. [PubMed] [Google Scholar]
- FEARNLEY G. R., VINCENT C. T., CHAKRABARTI R. Reduction of blood fibrinolytic activity in diabetes mellitus by insulin. Lancet. 1959 Dec 12;2(7111):1067–1067. doi: 10.1016/s0140-6736(59)91534-x. [DOI] [PubMed] [Google Scholar]
- MACKAY N., HUME R. FIBRINOLYTIC ACTIVITY IN DIABETES MELLITUS. Scott Med J. 1964 Sep;9:359–364. doi: 10.1177/003693306400900901. [DOI] [PubMed] [Google Scholar]
- TANSER A. R., SMELLIE H. OBSERVATIONS ON ADRENALINE-INDUCED FIBRINOLYSIS IN MAN. Clin Sci. 1964 Jun;26:375–380. [PubMed] [Google Scholar]